NextCure Inc. (NXTC) Financial Statements (2024 and earlier)

Company Profile

Business Address 9000 VIRGINIA MANOR ROAD, SUITE 200
BELTSVILLE, MD 20705
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

3/31/2024
MRQ
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments13,08226,63012,337283,448334,605
Cash and cash equivalents13,08226,63012,33732,77234,091
Short-term investments    250,676300,514
Restricted cash and investments   391,7061,706
Other undisclosed current assets99,643137,353215,4412,8243,684
Total current assets:112,725163,983227,817287,978339,995
Noncurrent Assets
Operating lease, right-of-use asset4,3985,016   
Property, plant and equipment9,03311,89713,99215,80912,090
Other noncurrent assets1,8823,2655772,8574,083
Total noncurrent assets:15,31320,17814,56918,66616,173
TOTAL ASSETS:128,038184,161242,386306,644356,168
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities3,3225,9096,3918,5286,732
Accounts payable2,3304,2701,9423,9011,861
Accrued liabilities 9921,6394,4494,6274,871
Debt    1,6671,667
Deferred rent credit   217130215
Other liabilities 113105   
Other undisclosed current liabilities3,4483,113  6,428
Total current liabilities:6,8839,1276,60810,32515,042
Noncurrent Liabilities
Long-term debt and lease obligation    1,8063,333
Long-term debt, excluding current maturities    1,8063,333
Liabilities, other than long-term debt6,7347,5042,392792359
Deferred rent credit   2,392792359
Other liabilities785899   
Operating lease, liability5,9496,605   
Other undisclosed noncurrent liabilities     15,950
Total noncurrent liabilities:6,7347,5042,3922,59819,642
Total liabilities:13,61716,6319,00012,92334,684
Equity
Equity, attributable to parent114,421167,530233,386293,721321,484
Common stock2828282827
Additional paid in capital439,097430,755421,047410,551402,529
Accumulated other comprehensive income (loss)(222)(1,494)(663)779(38)
Accumulated deficit(324,482)(261,759)(187,026)(117,637)(81,034)
Total equity:114,421167,530233,386293,721321,484
TOTAL LIABILITIES AND EQUITY:128,038184,161242,386306,644356,168

Income Statement (P&L) ($ in thousands)

3/31/2024
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Revenues    22,3786,347
Gross profit:    22,3786,347
Operating expenses(67,637)(75,909)(70,765)(63,603)(43,829)
Operating loss:(67,637)(75,909)(70,765)(41,225)(37,482)
Nonoperating income
(Other Nonoperating income)
4,9141,1761,3764,6223,745
Interest and debt expense    (183)(209)
Loss from continuing operations:(62,723)(74,733)(69,389)(36,786)(33,946)
Loss before gain (loss) on sale of properties:(69,389)(36,786)(33,946)
Other undisclosed net income    183209
Net loss available to common stockholders, diluted:(62,723)(74,733)(69,389)(36,603)(33,737)

Comprehensive Income ($ in thousands)

3/31/2024
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Net loss:(62,723)(74,733)(69,389)(36,603)(33,737)
Comprehensive loss:(62,723)(74,733)(69,389)(36,603)(33,737)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent1,272(831)(1,442)779(38)
Comprehensive loss, net of tax, attributable to parent:(61,451)(75,564)(70,831)(35,824)(33,775)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: